Skip to main content
Year archive

STARPHARMA HOLDINGS LIMITED — 2018 filings

All 48 regulatory filings released by STARPHARMA HOLDINGS LIMITED (SPL) in 2018, sourced directly from the official regulator.

48 Filings
2018 Period
2018 filings (48)
Filing Released Lang
Change in Director's Interest Notice - R Thomas 2 pages 80.1KB
Director's Dealing
2018-12-27 English
Change in Director's Interest Notice - J Fairley 2 pages 79.6KB
Director's Dealing
2018-12-27 English
Change in Director's Interest Notice - P Turvey 2 pages 79.1KB
Director's Dealing
2018-12-27 English
Ceasing to be a substantial holder 2 pages 488.0KB
Major Shareholding Notification
2018-12-26 English
US FDA requests further data for VivaGel BV approval 3 pages 132.3KB
Regulatory Filings
2018-12-26 English
US VivaGel BV licensed for A$142M milestones plus royalties 3 pages 139.3KB
Capital/Financing Update
2018-12-19 English
US patent granted for SPL7013 eye drops for conjunctivitis 2 pages 58.8KB
Regulatory Filings
2018-12-11 English
Becoming a substantial holder 2 pages 496.6KB
Major Shareholding Notification
2018-12-10 English
Appendix 3B 9 pages 182.2KB
Share Issue/Capital Change
2018-12-10 English
Change in Director's Interest Notice - J Fairley 2 pages 134.3KB
Director's Dealing
2018-12-10 English
AGM - Chairman address and CEO presentation 40 pages 3.6MB
AGM Information
2018-11-28 English
AGM Results 2 pages 161.2KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-28 English
DEP products outperform in human pancreatic cancer model 5 pages 387.4KB
Regulatory Filings
2018-11-15 English
Appendix 3B 8 pages 178.6KB
Share Issue/Capital Change
2018-11-04 English
Quarterly Cashflow Report 6 pages 248.0KB
Interim / Quarterly Report
2018-10-25 English
Notice of General Meeting/Proxy Form 14 pages 830.0KB
AGM Information
2018-10-25 English
Starpharma Investor Presentation for Citi Conference 35 pages 3.0MB
Investor Presentation
2018-10-16 English
Ceasing to be a substantial holder 2 pages 495.2KB
Major Shareholding Notification
2018-10-07 English
Appendix 3B 8 pages 173.7KB
Share Issue/Capital Change
2018-10-04 English
Change in Director's Interest Notice - J Fairley 2 pages 144.5KB
Director's Dealing
2018-10-04 English
Notification of AGM date 1 page 113.5KB
AGM Information
2018-10-01 English
Change in substantial holding 3 pages 507.8KB
Major Shareholding Notification
2018-09-13 English
DEP irinotecan outperforms in pancreatic cancer model 4 pages 153.9KB
Regulatory Filings
2018-09-04 English
AstraZeneca DEP Bcl2/xL inhibitors show compelling efficacy 4 pages 145.4KB
Regulatory Filings
2018-08-30 English
Annual report and full year financial results 94 pages 3.8MB
Annual Report
2018-08-20 English
Appendix 4G - Corporate Governance Statement 9 pages 187.3KB
Governance Information
2018-08-20 English
Quarterly Cashflow Report 6 pages 233.6KB
Interim / Quarterly Report
2018-07-16 English
VivaGel BV NDA advances to next stage of FDA review 2 pages 123.4KB
Regulatory Filings
2018-07-08 English
Starpharma licenses VivaGel BV to Mundipharma for Europe 3 pages 146.1KB
Capital/Financing Update
2018-06-26 English
Change in substantial holding 10 pages 436.9KB
Major Shareholding Notification
2018-06-05 English
Change in Director's Interest Notice - R Thomas 2 pages 124.5KB
Director's Dealing
2018-05-16 English
Mundipharma licenses Starpharma's VivaGel BV 3 pages 157.9KB
Capital/Financing Update
2018-05-02 English
Starpharma completes US New Drug Application for VivaGel BV 3 pages 151.9KB
Regulatory Filings
2018-04-29 English
Appendix 4C - Quarterly Cashflow Report 6 pages 172.4KB
Interim / Quarterly Report
2018-04-29 English
Starpharma to present at OTCQX Virtual Investor Conference 2 pages 55.8KB
Investor Presentation
2018-04-10 English
Change in Director's Interest Notice - J Fairley 2 pages 136.1KB
Director's Dealing
2018-03-20 English
Appendix 3B 8 pages 188.5KB
Share Issue/Capital Change
2018-03-19 English
Change in Director's Interest Notice - R Thomas 2 pages 120.7KB
Director's Dealing
2018-03-19 English
Change in Director's Interest Notice - R Thomas 2 pages 120.9KB
Director's Dealing
2018-03-14 English
Change in Director's Interest Notice - J Fairley 2 pages 80.7KB
Director's Dealing
2018-03-11 English
Change in Director's Interest Notice - P Turvey 2 pages 120.3KB
Director's Dealing
2018-03-11 English
Change in Director's Interest Notice - R Thomas 3 pages 144.4KB
Director's Dealing
2018-03-04 English
Interim Report and Half-Yearly Financial Results 23 pages 480.9KB
Interim / Quarterly Report
2018-02-25 English
Starpharma receives $3.7M R&D tax incentive refund 1
Capital/Financing Update
2018-02-21 English
Shareholder Update February 2018 4 pages 1.5MB
Investor Presentation
2018-02-18 English
Starpharma to commence DEP cabazitaxel phase 1/2 trial 2 pages 151.5KB
Regulatory Filings
2018-01-30 English
Appendix 3B 8 pages 191.2KB
Share Issue/Capital Change
2018-01-28 English
Appendix 4C - Quarterly Cashflow Report 6 pages 708.2KB
Interim / Quarterly Report
2018-01-24 English